| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.007 |